Yuka Takemon
Working Group Member
Related News Item
-
New computational tool provides clues on how to target cancers with KMT2D mutations
A new study led by Dr. Marco Marra describes a strategy for identifying potential novel treatment targets in cancers driven by the loss of genes that are classified as tumour suppressors.
-
Regional Consortia
BC Cancer Consortium
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more
-
-
Regional Consortia
BC Cancer Consortium
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more
-
-
Regional Consortia
BC Cancer Consortium
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more
-
-
Regional Consortia
BC Cancer Consortium
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more
-
-
Regional Consortia
BC Cancer Consortium
The overall vision of the BC Cancer Consortium is to further strengthen our province-wide research capabilities and partnerships, to improve our ability to support innovation in clinical care, and fir...Read more
-
